06 Sep, 2019 Sixth Annual RNAi Roundtable Series
We are hosting a series of online “RNAi Roundtables” at which Alnylam scientists and program leaders, clinical collaborators, and patients or patient advocates review recent progress in many of our late-stage pipeline programs and discuss the related disease areas.
Click on any of the RNAi Roundtables below to listen to the webcasts and view presentations from these events.
Patisiran & Vutrisiran, for the Treatment of Transthyretin-Mediated Amyloidosis
Monday, September 16, 1:00 pm ET
Givosiran, in Development for the Treatment of Acute Hepatic Porphyria
Monday, October 7, 9:30 am ET
Lumasiran, in Development for the Treatment of Primary Hyperoxaluria Type 1
Thursday, October 10, 11:30 am ET